بررسی شیوع آنتی بادی ضد هپاتیت E در بیماران همودیالیزی شهر تبریز در سال 1383
ANTI HEPATITIS E VIRUS ANTIBODY IN HEMODIALYSIS PATIENTS: A SEROEPIDEMIOLOGICAL SURVEY IN IRAN
نویسندگان: منوچهر خوشباطن , حسن ارگانی , سیما عابدی آذر
کلمات کلیدی: HEPATITIS E, HEMODIALYSIS PATIENTS, IGG ANTI-HEY, IRAN
نشریه: 0 , 6 , 9 , 2005
| نویسنده ثبت کننده مقاله |
سیما عابدی آذر |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات کلیه |
| کد مقاله |
72756 |
| عنوان فارسی مقاله |
بررسی شیوع آنتی بادی ضد هپاتیت E در بیماران همودیالیزی شهر تبریز در سال 1383 |
| عنوان لاتین مقاله |
ANTI HEPATITIS E VIRUS ANTIBODY IN HEMODIALYSIS PATIENTS: A SEROEPIDEMIOLOGICAL SURVEY IN IRAN |
| ناشر |
9 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
RESEARCHER BULLETIN OF MEDICAL SCIENCES (PEJOUHANDEH) |
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح چهار – SID/Iranmedex/Magiran |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Abstract:
Background: The hepatitis E virus (HEV) has a global distribution and is known to have caused large waterborne epidemics of icteric hepatitis. Transmission is generally via the fecal oral route. Some reports have suggested parenterally transmission of HEV. Anti-HEV prevalence data among chronic hemodialysis (HD) patients are few and given conflicting results.
Materials and Methods: This cross-sectional study was conducted in August of 2004.We tested 324 chronic HD patients attending three different units in the city of Tabriz, in the northwestern part of Iran, for anti-HEV antibody. A specific solid- phase enzyme-linked immunoassay (Diapro, Italy) was used.
Results: The overall seroprevalence of hepatitis E was7.4% (95% CI: 4.6%-10.6%).The prevalence rate of HBV and HCV infection were 4.6% (95% CI: 2.3%-6.9%) and 20.4% (95% CI: 16%-24.8%) respectively. The seroprevalence of anti-HEV antibody among chronic HD patients was associated significantly with age. No statistically significant association was observed between HEV seropositivity and other variables.
Conclusion: We observed high anti-HEV prevalence; there was no association between HEV and blood borne infections (HBV, HCV, HIV) in our HD patients; most anti -HEV positive patients we found were probably related to a local infection by HEV. This is the first report concerning seroepidemiology of HEV infection in a large cohort of chronic HD individuals in Iran. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 91137977.pdf | 1399/07/14 | 163332 | دانلود |